- Mar 2022
-
www.cnn.com www.cnn.com
-
CNN, A. S. (n.d.). Pfizer begins Phase 2 and 3 trial of Covid-19 antiviral Paxlovid in children ages 6 to 17. CNN. Retrieved 22 March 2022, from https://www.cnn.com/2022/03/09/health/pfizer-paxlovid-pediatric-trial/index.html
-
- Feb 2022
-
-
Mancini, D. P., & Smyth, J. (2022, February 16). Merck struggles to win European approval for Covid-19 antiviral pill. Financial Times. https://www.ft.com/content/2cf0b6cc-b07b-4ff9-a833-42eb1798a576
-
- Jan 2022
-
medicalxpress.com medicalxpress.com
-
Tong-Hyung, K. (n.d.). South Korea gets first supply of Pfizer’s COVID-19 pills. Retrieved January 20, 2022, from https://medicalxpress.com/news/2022-01-south-korea-pfizer-covid-pills.html
-
- Nov 2021
-
www.theguardian.com www.theguardian.com
-
France-Presse, A. (2021, November 17). Pfizer strikes deal to allow generic versions of its Covid pill for world’s poor. The Guardian. https://www.theguardian.com/business/2021/nov/17/pfizer-strikes-deal-to-allow-generic-versions-of-its-covid-pill-for-worlds-poor
Tags
- Paxlovid
- antiviral pill
- approval
- Pfizer
- manufacturer
- income
- public health emergency
- cost
- royalty
- lang:en
- vaccine
- funding
- COVID-19
- is:news
- treatment
Annotators
URL
-